# F-Prime Capital's Biotech Investments: 48 Startups in Its Portfolio (2026)

> The 48 Biotech startups F-Prime Capital has backed, by stage: $6.7B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/f-prime-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Series C and later

16

- [Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines)
- [*IM* Insilico Medicine](https://millionrounds.com/company/insilico-medicine)
- [Innovent Biologics](https://millionrounds.com/company/innovent-biologics)
- [Coherus Biosciences](https://millionrounds.com/company/coherus-biosciences)
- [*O* Oviva](https://millionrounds.com/company/oviva)
- [TraceLink](https://millionrounds.com/company/tracelink)
- [Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)
- [Pulmocide](https://millionrounds.com/company/pulmocide)
- [Quartet](https://millionrounds.com/company/quartet)
- [Adagene](https://millionrounds.com/company/adagene)
- [PharmEasy](https://millionrounds.com/company/pharmeasy)
- [ABK Biomedical](https://millionrounds.com/company/abk-biomedical)
- [*MT* Menlo Therapeutics](https://millionrounds.com/company/menlo-therapeutics)
- [Artemis Health](https://millionrounds.com/company/artemis-health)
- [*PP* Promentis Pharmaceuticals](https://millionrounds.com/company/promentis-pharmaceuticals)
- [Wellframe](https://millionrounds.com/company/wellframe)

## Series B

15

- [Denali Therapeutics](https://millionrounds.com/company/denali-therapeutics)
- [Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics)
- [T-Therapeutics](https://millionrounds.com/company/t-therapeutics)
- [Hua Medicine](https://millionrounds.com/company/hua-medicine)
- [Semma Therapeutics](https://millionrounds.com/company/semma-therapeutics)
- [US HealthVest](https://millionrounds.com/company/us-healthvest)
- [SonoThera](https://millionrounds.com/company/sonothera)
- [Nocion Therapeutics](https://millionrounds.com/company/nocion-therapeutics)
- [NodThera](https://millionrounds.com/company/nodthera)
- [Checkmate Pharmaceuticals](https://millionrounds.com/company/checkmate-pharmaceuticals)
- [*A* Avidity](https://millionrounds.com/company/avidity)
- [WelbeHealth](https://millionrounds.com/company/welbehealth)
- [*PH* Procured Health](https://millionrounds.com/company/procured-health)
- [Avidity NanoMedicines](https://millionrounds.com/company/avidity-nanomedicines)
- [Buoy Health](https://millionrounds.com/company/buoy-health)

## Series A

9

- [Verve Therapeutics](https://millionrounds.com/company/verve-therapeutics)
- [*RT* R1 Therapeutics](https://millionrounds.com/company/r1-therapeutics)
- [*GP* Genoa Pharmaceuticals](https://millionrounds.com/company/genoa-pharmaceuticals)
- [*AT* Akrevia Therapeutics](https://millionrounds.com/company/akrevia-therapeutics)
- [Modis Therapeutics](https://millionrounds.com/company/modis-therapeutics)
- [Countable Labs](https://millionrounds.com/company/countable-labs)
- [Embark Veterinary](https://millionrounds.com/company/embark-veterinary)
- [*NH* Notabel Health](https://millionrounds.com/company/notabel-health)
- [*AT* Akreveia Therapeutics](https://millionrounds.com/company/akreveia-therapeutics)

## Stage not reported

6

- [Leyden Labs](https://millionrounds.com/company/leyden-labs)
- [*P* Precision](https://millionrounds.com/company/precision)
- [*CP* Caplin Point](https://millionrounds.com/company/caplin-point)
- [*O* Orchard](https://millionrounds.com/company/orchard)
- [Novaerus](https://millionrounds.com/company/novaerus)
- [LunaPBC](https://millionrounds.com/company/lunapbc)

## Pre-seed and seed

2

- [Nebula Genomics](https://millionrounds.com/company/nebula-genomics)
- [Tempest](https://millionrounds.com/company/tempest)

## Segment by segment

### Series C and later

16 startups · $3.6B raised

- [**Blueprint Medicines**](https://millionrounds.com/company/blueprint-medicines) Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. United States $1.4B
- [*IM* **Insilico Medicine**](https://millionrounds.com/company/insilico-medicine) Hong Kong SAR China $392M
- [**Innovent Biologics**](https://millionrounds.com/company/innovent-biologics) Established in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for China $385M
- [**Coherus Biosciences**](https://millionrounds.com/company/coherus-biosciences) Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases. United States $299M
- [*O* **Oviva**](https://millionrounds.com/company/oviva) Switzerland $246M
- [**TraceLink**](https://millionrounds.com/company/tracelink) TraceLink is a leading digital network platform that specializes in the orchestration of the pharmaceutical and life sciences supply chain. United States $174M
- [**Mersana Therapeutics**](https://millionrounds.com/company/mersana-therapeutics) Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines. United States $148M
- [**Pulmocide**](https://millionrounds.com/company/pulmocide) Pulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007. United Kingdom $110M

### Series B

15 startups · $2.2B raised

- [**Denali Therapeutics**](https://millionrounds.com/company/denali-therapeutics) Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families. United States $547M
- [**Beam Therapeutics**](https://millionrounds.com/company/beam-therapeutics) Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology. United States $322M
- [**T-Therapeutics**](https://millionrounds.com/company/t-therapeutics) T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. United Kingdom $279M
- [**Hua Medicine**](https://millionrounds.com/company/hua-medicine) Hua Medicine is a clinical-stage, innovative drug development company in China. China $192M
- [**Semma Therapeutics**](https://millionrounds.com/company/semma-therapeutics) Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. United States $158M
- [**US HealthVest**](https://millionrounds.com/company/us-healthvest) US HealthVest is a behavioral healthcare firm that helps the development of psychiatric hospitals. United States $141M
- [**SonoThera**](https://millionrounds.com/company/sonothera) SonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies. United States $125M
- [**Nocion Therapeutics**](https://millionrounds.com/company/nocion-therapeutics) Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. United States $112M

### Series A

9 startups · $464M raised

- [**Verve Therapeutics**](https://millionrounds.com/company/verve-therapeutics) Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease. United States $202M
- [*RT* **R1 Therapeutics**](https://millionrounds.com/company/r1-therapeutics) United States $78M
- [*GP* **Genoa Pharmaceuticals**](https://millionrounds.com/company/genoa-pharmaceuticals) Genoa Pharmaceuticals developes improved therapies for the treatment of Idiopathic Pulmonary Fibrosis (IPF). United States $63M
- [*AT* **Akrevia Therapeutics**](https://millionrounds.com/company/akrevia-therapeutics) United States $30M
- [**Modis Therapeutics**](https://millionrounds.com/company/modis-therapeutics) Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases. United States $30M
- [**Countable Labs**](https://millionrounds.com/company/countable-labs) Countable Labs is a biotechnology company based in Palo Alto, California, focused on next-generation genomics and precision DNA qu United States $26M
- [**Embark Veterinary**](https://millionrounds.com/company/embark-veterinary) Embark Veterinary is a Boston-based company specializing in canine genomics and biotechnology, founded in 2015. United States $15M
- [*NH* **Notabel Health**](https://millionrounds.com/company/notabel-health) United States $14M

### Stage not reported

6 startups · $411M raised

- [**Leyden Labs**](https://millionrounds.com/company/leyden-labs) Leyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions fo Netherlands $221M
- [*P* **Precision**](https://millionrounds.com/company/precision) United States $111M
- [*CP* **Caplin Point**](https://millionrounds.com/company/caplin-point) India $31M
- [*O* **Orchard**](https://millionrounds.com/company/orchard) United States $30M
- [**Novaerus**](https://millionrounds.com/company/novaerus) Novaerus Improve the business and quality of care through the application of airborne pathogen control technology. United States $10M
- [**LunaPBC**](https://millionrounds.com/company/lunapbc) LunaPBC is a healthcare company that transforms health data into health breakthroughs. United States $8.4M

### Pre-seed and seed

2 startups · $7.5M raised

- [**Nebula Genomics**](https://millionrounds.com/company/nebula-genomics) Nebula Genomics is a personal genomics company based in San Francisco, California, founded in 2016 by Dr. United States $4.3M
- [**Tempest**](https://millionrounds.com/company/tempest) Tempest is a Celtic rock band based in the San Francisco Bay Area, active since 1988. United States $3.2M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names F-Prime Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **F-Prime Capital's Healthtech portfolio** 11 startups · $1.1B](https://millionrounds.com/portfolio-maps/f-prime-healthtech-portfolio)[Sector portfolio **F-Prime Capital's Fintech portfolio** 11 startups · $853M](https://millionrounds.com/portfolio-maps/f-prime-fintech-portfolio)[Co-investors **Who invests with F-Prime Capital** 107 co-investors](https://millionrounds.com/portfolio-maps/f-prime-co-investors)[Portfolio map **F-Prime Capital portfolio map** 87 startups · $11B](https://millionrounds.com/portfolio-maps/f-prime-portfolio-map)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)

## Raising from investors like F-Prime Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
